Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance
Authors:
- Einfrid Åm HolenEHEinfrid Åm Holen
- Geir TangenGTGeir Tangen
- Mari-Anne L. RingdalMRMari-Anne L. Ringdal
- 1 October 1996
- journal article
- clinical trial
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 62 (4) , 1128-1133
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Eosinophil granulocyte activation and heparin-coated cardiopulmonary bypassThe Annals of Thoracic Surgery, 1996
- Complete heparin-coated cardiopulmonary bypass and low heparin dose reduce complement and granulocyte activationEuropean Journal of Cardio-Thoracic Surgery, 1996
- Complement and granulocyte activation in two different types of heparinized extracorporeal circuitsThe Journal of Thoracic and Cardiovascular Surgery, 1995
- Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypassThe Annals of Thoracic Surgery, 1995
- Consistent non-pharmacologic blood conservation in primary and reoperative coronary artery bypass graftingEuropean Journal of Cardio-Thoracic Surgery, 1995
- Complement activation during cardiopulmonary bypass: Effects of immobilized heparinThe Annals of Thoracic Surgery, 1994
- Heparin-coated bypass circuits reduce pulmonary injuryThe Annals of Thoracic Surgery, 1993
- Decreased Blood Loss After Cardiopulmonary Bypass using Heparin-Coated Circuit and 50% Reduction of Heparin DoseScandinavian Journal of Thoracic and Cardiovascular Surgery, 1992
- Principles of heparin-coating techniquesPerfusion, 1991
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981